Peter Lynch fit · Growth at a reasonable price (GARP)
Is Incyte Genomics Inc (INCY) a Peter Lynch Stock?
Does not fit Lynch's GARP criteria — growth too low or price too high.
15/100
FNo encaja
3/6 criterios cumplidos
Los criterios de Peter Lynch, aplicados a INCY
PEG ≤ 1.0
clave—
EPS CAGR ≥ 15%
clave0.0%
Revenue CAGR ≥ 10%
-6.8%
Net margin > 0
24.7%
Cómo se valora INCY en otras estrategias
Datos financieros en vivo
Cap. mercado
$20.63B
PER (TTM)
667.1x
ROIC (TTM)
0.22%
Margen bruto
91.91%
Preguntas frecuentes
What is INCY's Peter Lynch fit score?
INCY scores 15/100 on our Peter Lynch fit engine — grade F. Does not fit Lynch's GARP criteria — growth too low or price too high.
Does Peter Lynch actually own INCY?
Our score is computed from financial fundamentals against Peter Lynch's published criteria. We don't claim that Peter Lynch personally owns or recommends INCY.
How often is this score updated?
INCY's Peter Lynch fit score is recomputed daily from the latest TTM financials.
Herramienta educativa, no es asesoramiento financiero. Las puntuaciones se calculan a partir de datos financieros públicos contra los criterios publicados de cada estrategia de inversión. No afirmamos que Peter Lynch posea o recomiende INCY personalmente.